Psychology & Intimacy Breakthrough Neuroinflammation Research Identifies Existing Drug Target to Combat Alzheimer’s, Parkinson’s, and Traumatic Brain Injury October 15, 2026 Rebecca Shoemaker Scientists at the University of Birmingham have unveiled a promising therapeutic pathway to mitigate harmful neuroinflammation by zeroing in on a cellular receptor that is already compatible with existing pharmacological…
Psychology & Intimacy Groundbreaking Neuroinflammation Study Identifies Existing Drug Target to Combat Brain Disorders and Neurodegeneration October 8, 2026 Rebecca Shoemaker Medical science may stand on the brink of a major therapeutic breakthrough following the publication of a new study in the academic journal Brain. Led by Professor Nicholas Barnes at…
Psychology & Intimacy New Research Reveals How APOE4 Triggers Early Brain Changes and Identifies Potential Pathway for Alzheimer’s Reversal September 20, 2026 Rebecca Shoemaker Millions of individuals worldwide carry APOE4, widely recognized as the most potent genetic risk factor for the development of late-onset Alzheimer’s disease. For decades, the precise biological mechanisms by which…
Psychology & Intimacy Groundbreaking Gladstone Institutes Study Reveals How APOE4 Accelerates Alzheimer’s Risk and Identifies Potential Reversal Target September 12, 2026 Rebecca Shoemaker The pursuit of effective interventions for Alzheimer’s disease has long been stymied by the complex interplay between genetic predisposition and neurodegeneration. Millions of individuals globally carry the APOE4 gene variant,…
Psychology & Intimacy Single-nucleus chromatin accessibility profiling identifies cell types and functional variants contributing to major depression June 2, 2026 Rebecca Shoemaker A groundbreaking discovery by researchers at McGill University and the Douglas Institute is poised to revolutionize our understanding of depression, identifying for the first time specific brain cell types that…
Sexual Health & Medical Wellness A New Era in Early Cancer Detection: HPV-DeepSeek Identifies Head and Neck Cancers Up to a Decade Before Symptoms Emerge June 2, 2026 Susilo Ahmad Human papillomavirus (HPV) is the causative agent for approximately 70% of head and neck cancers (HNC) in the United States, positioning it as the foremost HPV-related malignancy and one exhibiting…
Psychology & Intimacy Single-nucleus chromatin accessibility profiling identifies cell types and functional variants contributing to major depression May 22, 2026 Rebecca Shoemaker A groundbreaking study by researchers at McGill University and the Douglas Institute has unveiled a critical insight into the biological underpinnings of depression, identifying for the first time specific types…
Psychology & Intimacy Single-nucleus chromatin accessibility profiling identifies cell types and functional variants contributing to major depression May 15, 2026 Rebecca Shoemaker Researchers at McGill University and the Douglas Institute have unveiled groundbreaking insights into the biological underpinnings of depression, identifying two distinct types of brain cells that exhibit altered function in…
Psychology & Intimacy Single-nucleus chromatin accessibility profiling identifies cell types and functional variants contributing to major depression May 8, 2026 Rebecca Shoemaker Researchers at McGill University and the Douglas Institute have unveiled groundbreaking insights into the biological underpinnings of depression, identifying two distinct types of brain cells that exhibit altered functionality in…
Psychology & Intimacy Single-nucleus chromatin accessibility profiling identifies cell types and functional variants contributing to major depression April 30, 2026 Rebecca Shoemaker A groundbreaking study by researchers at McGill University and the Douglas Institute has unveiled critical new insights into the biological underpinnings of depression, identifying two distinct types of brain cells…
